← All organizations
Highest phase reached
Phase 2
Acquired by Jubilant Industries → Jubilant Innovation Ltd. on Jun 1, 2008
Timeline
1970s
- Jun 1, 1978
1980s
- Dec 29, 1989
technetium tc-99m pentetate kit— Marketing Organization
2000s
- Jan 24, 2003
sodium iodide i-131— NDA Secondary Org
- May 28, 2008
Draximage— Acquired
- Jun 1, 2008
Jubilant DraxImage Inc.— Founded
- Jun 1, 2008
Jubilant Industries— Acquired By
Drugs by trial phase (6 distinct, 7 trials)
Phase 2 (4 own, 2 via acquisition)
Indications
Marketed drugs (11)
- sodium fluoride (18F)
- technetium tc-99m sestamibi
- radiolabeled albumin technetium Tc-99m albumin colloid kit
- technetium tc-99m sulfur colloid kit
- technetium tc-99m mertiatide kit
- technetium-99m exametazine
- technetium tc-99m pentetate kit
- fludeoxyglucose f-18
- sodium iodide i-131
- technetium tc-99m medronate kit
- rubidium chloride rb-82
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (6)
- NCT07261241CollaboratorPhase 2Jul 31, 2026
- NCT05268666Lead sponsorPhase 1/Phase 2Apr 8, 2022
- NCT05268666Study directorPhase 1/Phase 2Apr 8, 2022
- NCT03561259Study directorPhase 2Jul 31, 2018
- NCT03561259Lead sponsorPhase 2Jul 31, 2018
- NCT01590680Lead sponsorN/AMay 1, 2012
Details
- Founded
- IN Jun 1, 2008
- Last known activity
- Jul 31, 2026